Innovating Works

NCARDIA SERVICES BV

Desconocido
PersonalizeAF: Personalized Therapies for Atrial Fibrillation. A Translational Approach NCARDIA SERVICES BV participó en un H2020: H2020-MSCA-ITN-2019 Atrial Fibrillation (AF) is the most common cardiac arrhythmia affecting more than 6 million Europeans with a cost exceeding 1% of the EU he...
2019-09-11 - 2024-03-31 | Financiado
INSPIRE: INnovation in Safety Pharmacology for Integrated cardiovascular safety assessment to REduce adverse... NCARDIA SERVICES BV participó en un H2020: H2020-MSCA-ITN-2019 New drug candidates often have off-target effects resulting in adverse events, thus representing a major limitation for drug R&D. Safety Pha...
2019-08-19 - 2024-05-31 | Financiado
* Datos extraídos de la documentos o webs disponibles en diferentes organismos públicos.